ESMO 2025

Keytruda
Pharma

FDA endorses Merck's Keytruda for the 1st time in ovarian cancer

Thirteen years after the FDA first blessed Keytruda for melanoma, the agency has approved the PD-1 superstar for a certain type of ovarian cancer.
Kevin Dunleavy Feb 11, 2026 10:04am
VanNaarden
Favicon Fierce Biotech

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am
Blue race track

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm
Akeso

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am
NVS

Novartis' Pluvicto slows progression in earlier prostate cancer

Oct 19, 2025 10:30am
AZ

AZ faces FDA challenge as Imfinzi-Lynparza miss survival goal

Oct 19, 2025 4:15am